May 9, 2026
India’s pharmaceutical industry is entering a new phase of accountability and transparency. The country’s drug regulator, Central Drugs Standard Control Organization (CDSCO), has introduced stricter rules […]
May 9, 2026
India’s pharmaceutical industry has once again proved why it is called the “pharmacy of the world.” Despite economic uncertainty, supply chain disruptions, and slowing demand in […]
May 9, 2026
India has once again emerged at the center of the global pharmaceutical conversation after the Global Trade Research Initiative (GTRI) stated that the country supplies nearly […]
April 24, 2026
India’s biotechnology sector is no longer an emerging story—it is a rapidly accelerating force. Valued at nearly $195 billion in 2025 and contributing close to 5% […]
April 20, 2026
India’s pharmaceutical industry, often hailed as the “pharmacy of the world,” faced an unexpected setback in March as exports dropped to a five-year low. This decline, […]
April 20, 2026
The Indian pharmaceutical market closed FY26 on a strong and encouraging note, signaling a shift from sluggish volume trends to a more stable and growth-oriented phase. […]
March 23, 2026
India’s pharmaceutical industry has long been celebrated as the “pharmacy of the world,” supplying affordable medicines across continents. Yet, behind this success lies a regulatory framework […]
March 23, 2026
The pharmaceutical world is witnessing a transformative moment with the rise of generic semaglutide. Originally developed as a breakthrough therapy for type-2 diabetes and later recognized […]
March 21, 2026
The Indian pharmaceutical industry is undergoing a transformative shift—one where Environmental, Social, and Governance (ESG) performance is no longer optional but central to long-term capital strategy. […]